Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without evidence.
Hellmann
Kurt
K
D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D002648:Child; D002986:Clinical Trials as Topic; D006689:Hodgkin Disease / Q000139:chemically induced* / Q000473:pathology*; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced* / Q000209:etiology*; D011929:Razoxane / Q000009:adverse effects*; D012107:Research Design; D012306:Risk; D012307:Risk Factors
D000970:Antineoplastic Agents; D011929:Razoxane